Expanding Capacity During Industry Consolidation: A Long View of the Early-Stage Clinical Research Marketplace

Biopharma leaders who monitor the clinical research market are aware of recent supply/demand asymmetry in the early-stage research marketplace. Indeed, research capacity, especially within North America, has outstripped demand for some time. The specific causes of this capacity mismatch are numerous, of course. But at base, the equation is straightforward: Continuing high research capacity plus dwindling demand equals ongoing oversupply… read more.